These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 647639)
1. Well differentiated adenocarcinoma of the prostate. Kern WH Cancer; 1978 May; 41(5):2046-54. PubMed ID: 647639 [TBL] [Abstract][Full Text] [Related]
2. [Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification]. Uchida T; Go M; Nakajo H; Takagi Y; Murayama M; Honda N; Igarashi M; Ishibashi A; Koshiba K Hinyokika Kiyo; 1988 Jan; 34(1):116-22. PubMed ID: 3376792 [TBL] [Abstract][Full Text] [Related]
3. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. Hattab EM; Koch MO; Eble JN; Lin H; Cheng L J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733 [TBL] [Abstract][Full Text] [Related]
8. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Genega EM; Hutchinson B; Reuter VE; Gaudin PB Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Gleason system use on different types of prostatic tissue samples. Pleşea IE; Zaharia B; Enache SD; Mitroi G; Tomescu P; Pop OT; Badea P; Kozokić A Rom J Morphol Embryol; 1999-2004; 45():25-34. PubMed ID: 15847376 [TBL] [Abstract][Full Text] [Related]
10. [Reproducibility of malignancy grading in prostatic cancers using the Gleason-Böckling system]. Kiss F; Lakner G; Csellár M; Nagy P; Tóth A; Vittay G Orv Hetil; 1997 May; 138(19):1195-9. PubMed ID: 9235527 [TBL] [Abstract][Full Text] [Related]
11. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading]. Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974 [TBL] [Abstract][Full Text] [Related]
12. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid carcinoma of the prostate: a study of 42 cases. Hansel DE; Epstein JI Am J Surg Pathol; 2006 Oct; 30(10):1316-21. PubMed ID: 17001164 [TBL] [Abstract][Full Text] [Related]
14. Updates on Grading and Staging of Prostate Cancer. Braunhut BL; Punnen S; Kryvenko ON Surg Pathol Clin; 2018 Dec; 11(4):759-774. PubMed ID: 30447840 [TBL] [Abstract][Full Text] [Related]
15. A histopathological study of carcinoma of the prostate in Port Harcourt, Nigeria. Obiorah CC; Nwosu SO Niger J Clin Pract; 2011; 14(3):363-7. PubMed ID: 22037086 [TBL] [Abstract][Full Text] [Related]
16. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
17. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases. Parwani AV; Herawi M; Epstein JI Am J Surg Pathol; 2006 Oct; 30(10):1254-9. PubMed ID: 17001156 [TBL] [Abstract][Full Text] [Related]
18. [The value of the modified Gleason grading system of prostate adenocarcinoma in routine urological diagnostics]. Helpap B; Egevad L Urologe A; 2007 Jan; 46(1):59-62. PubMed ID: 17111167 [TBL] [Abstract][Full Text] [Related]
19. Foamy gland adenocarcinoma of the prostate: incidence, Gleason grade, and early clinical outcome. Hudson J; Cao D; Vollmer R; Kibel AS; Grewal S; Humphrey PA Hum Pathol; 2012 Jul; 43(7):974-9. PubMed ID: 22221706 [TBL] [Abstract][Full Text] [Related]